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Abstract: 
 Iron deficiency in human infants and in young animal models produces changes in neural functioning that may 
be related to monoamine metabolism. This study employed both behavioral and biochemical approaches in a 
design using cross-fostering to examine alterations in dopamine (DA) function when iron deficiency occurs 
during the neonatal period. We measured brain Fe, dopamine transporters (DAT) and dopamine receptor density 
In rats made iron deficient, or not, from postnatal day (PND) 4 to PND 14 or 21. Some pups were then weaned 
to an iron-deficient diet and others to the control diet to examine the reversibility of these effects. Behaviors 
related to dopamine function were measured. Dopamine D2 receptor (D2R), D,R and iron concentrations were 
~70, 80 and 30% of control values, respectively, in the nucleus accumbens and striatum in Iron-deficient rats at 
PND 14. The DAT density was also reduced to 50% of control density In the nucleus accumbens but was 
unchanged in the striatum. By PND 21, there was also a significant 50% lowering of DAT, D,R and D2R 
densities in the prefrontal cortex (PFC). Iron repletion at PND 21-49 normalized D1R, D2R, and DAT levels in 
the nucleus accumbens, PFC and ventral midbrain but not in the striatum. In summary, neonatal Iron deficiency 
is associated with changes in DA biology that vary with duration of iron deficiency, and are not completely 
normalized despite replenishment of iron status. Changes in DA-related behaviors that were persistent after 
postweaning iron repletion suggest the existence of a critical neonatal developmental period that is expressed by 
alterations in DA functioning. J. Nut, 133: 1174-1179, 2003. 
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Article: 
Iron is involved in numerous neurological functions. The effects of iron deficiency (ID)
2
 on behavior have been 
widely investigated in humans and in experimental animals. Studies in adults and in children demonstrate that 
iron deficiency is associated with apathy, irritability, lethargy, lack of concentration, increased anxiety, 
hypoactivity, and decreased cognition and attention. Despite major methodological differences among early 
(1,2) and later studies [reviewed in (3-7)1, remarkably similar results are reported. The biological basis of 1D-
related cognitive and behavioral alterations is unclear; however, a conceptual model of contributing factors 
must include environmental as well as biological factors (4,8). The biological variables are related to decreased 
brain iron, and likely include hypomyelination, impaired dopaminergic function and delayed neuromaturation 
(8-10). Auditory evoked potential studies in 6-mo-old iron-deficient infants showed increased central 
conduction times consistent with either hypomyelination or altered monoamine metabolism (10). One way of 
determining causality is to utilize animal models that focus on the relationship of neurotransmitters in limbic 
structures to behaviors that appear to be adversely affected by iron deficiency in human infants (4). 
 
The effects of iron on neurological functioning in rodents are related to the brain levels of iron, not to anemia 
per se (11,12), Induction of iron deficiency in postweaning rats results in decreased densities of dopamine (DA) 
D2 receptors (D1R), increased extracellular DA, and blunted DA reuptake in vivo, (12-14), Iron-deficient rats 
are less active than control rats when placed in a novel environment; they explore less and are more "fearful" 
than control rats (15,16). These behaviors are dependent in part on dopaminergic function in nigrostriatal and 
mesocorticolimbic pathways and are the basis for our somewhat selective examination of certain brain regions. 
The previously cited studies demonstrated a reversible relationship of regional brain iron to DA and to 
behaviors, but they did not identify a "critical period" of development, In human infants suffering from iron 
deficiency, that critical period appears to be during the first 12-18 mo of life. 
 
Rodent studies of neonatal iron deficiency demonstrated developmentally dependent rates of depletion of brain 
iron with dietary deficiency and a failure to correct abnormal behaviors even though the regional brain iron 
contents were restored to normal levels within 2 wk of feeding a high iron diet (17). In the current studies, we 
investigated the relationship of neonatal iron deficiency with dopamine metabolism; furthermore, we sought to 
determine whether the above-mentioned effects were normalized after dietary iron intervention. 
 
MATERIALS AND METHODS 
Design. An out-fostering regimen was implemented to produce iron deficiency postnatally but before weaning 
in pups, as described by Pinero et al. (17). On postnatal day (PND) 4 of life, we placed iron-sufficient pups with 
lactating darns that had been fed an iron-deficient diet from midgestation to term. We then conducted an 
intervention study with experimental groups in which rats were made iron deficient between PND 4 and 14, 
between PND 4 and 21 or between PND 21 and 49. To examine reversibility of effect, we also included rats 
made iron deficient between days 4 and 21 and subsequently fed an iron-sufficient diet until d 49 of age. Each 
experimental group was compared with a control cohort group fed an iron-sufficient diet. All experimental (and 
control) rats were killed on the day of the regimen as specified. 
 
Animals and dietary treatment. Male and female Sprague-Dawley rats (180-200 and 140-160 g, respectively) 
were purchased from Harlan Sprague Dawley (Indianapolis, IN). The female rats were fed a control diet (35 Fe 
mg/kg diet) and the males were fed a standard nonpurified diet (Laboratory Rodent Diet, PMI Nutrition Interna-
tional, Brentwood, MO). At age 49 d, the females were mated with a male for 5 d (two females and one male), 
after which the females were removed and placed in individual home cages. Pregnancy was defined by the 
appearance of vaginal plugs. The dams were weighed every other day to confirm the pregnancies. 
 
After pregnancy was determined, the dams were fed an iron-deficient diet (3 mg Fe/kg diet) at midgestation or 
continued to consume the control diet. The first morning that the pups appeared in the cages was considered 
PND 1. At PND 4, rats from the control dams were randomly assigned to iron-deficient dams or to dams fed the 
control (CN) diet. To control for the effects of outfostering, per se, a number of pups born to control dams were 
fostered with another control dam until weaning. Some of these pups were then weaned to a low iron diet (3 mg 
Fe/kg) and others to a control diet (35 mg Fe/kg). No pups utilized in these studies experienced iron deficiency 
in utero. There were roughly equal numbers of male and female pups in each litter, but only data from males are 
included. Although we did not measure milk iron and pup milk consumption, previous studies (17,18) 
demonstrated that this protocol decreases milk iron concentration and that pups consume normal amounts of 
milk per gram of body weight. 
 
Dietary treatment. The diets were prepared as described elsewhere, (18) and met all nutrient requirements with 
the exception of iron in the low iron diet. All diets were formulated according to the guidelines of the AIN, with 
cornstarch as the sole source of carbohydrate (19). By analysis, the diet iron concentrations were 36.7 ± 0.7 mg 
Fe/kg for the control diet and 3.15 ± 0,5 mg Fe/kg for the iron-deficient diet. All rats had free access to food and 
water 24 hid, and lights were turned off between 1800 and 0600 h. The room temperature was maintained at 25 
± 1°C. The Pennsylvania State University Animal Care and Use Committee approved all animal procedures. 
 
The iron status of the dams was closely monitored by measuring hemoglobin (Hb) and hematocrit (Net) before 
mating, at midpregnancy, at delivery, at midlactation and at weaning as previously described (17). 
 
Hematological and liver nonheme iron. Hemoglobin was measured colorimetrically by the 
cyanomethemoglobin method and Hct was determined by centrifugation (9,000 g, for 5 min) of blood collected 
into heparinized microcapillary tubes. Liver nonheme iron was determined using the standard colorimetric 
technique described by Cook (20) with ferrozine as the color reagent. 
 
Iron repletion. Separate groups of ID rats were weaned to a control diet for 4 wk (IDCN) starting at PND 21. 
Corresponding age-matched control rats (CNCN) that were iron sufficient at all times were also used. After 4 
wk of dietary iron repletion, behavioral measures were obtained before killing and brain iron and dopamine 
variables were measured. 
 
Locomotor behavior tests. Rats at PND 21 and after 4 wk of iron repletion were subjected to behavior tests 
(ambulation and stereotypy) via an automated activity monitor according to methods previously described 
(21,22). 
 
Densities of dopamine receptors and the dopamine transporter (DAT). Brains from freshly killed rats were 
dissected, membrane fractions prepared and radioligand binding assays performed as described previously 
(22,23). The ligands used were 
3
H-SCH23390, '
25
I-epidepride and 
3
H-GBR 12935 for D1R, D2R and the DAT, 
respectively. All assays were conducted in random order. Maximum binding values were normalized to protein 
concentrations as determined by the micro-I.owry assay (P5656 Sigma Chemical, Natick, MA). 
Iron analysis. Total iron content of brain region homogenates was determined using atomic absorption 
spectrophotoinetry (24). 
 
Statistical analysis. Dopamine receptor and transport measures were analyzed by ANOVA. The between-
subject factor was diet and the within-subject factor was brain region. The behavioral variables were subjected 
to ANOVA for a between-subjects variables analysis (diet). Student's t test for samples with unequal variances 
was used to test effects of dietary treatment on hematological measures and liver nonheme iron. Tukey's 
Honestly Significant Difference post-hoc test was used to evaluate differences between means with a set at P < 
0.05. Estimated tu
2
 were calculated for significant main effects and interaction to show the proportion of 
variance in the measure attributable to the factor or to interaction (25). 
 
RESULTS 
Biological data. The period of early neonatal ID refers to the dietary iron deficiency n=induced between PND 4 
and 14. Complete neonatal iron deficiency refers to iron deficiency from PND 4 to 21. Hermatologic indices 
demonstrated that rats cross-fostered to iron-deficient dams were iron deficient at PND 14 and 21 and has 
significantly lower body weights than controls (Table 1). There were age- and region-specific effects of iron 
deficiency on brain iron concentration. For example, at PND 14, iron-deficient rats had a slightly higher 
concentration of iron in the prefrontal cortex (PFC) than control rats, but 60-70% lower concentrations in 
striatum and nucleus accumbens [F (1,12) = 12.4, est. ω
2
 = 0.143]. Another week of dietary iron deficiency to 
PND 21 diminished the rapid accumulation of iron in the PFC and ventral midbrain compared with controls [F 
(1,12) = 18.6, est. ω
2
 = 0.347] but did not prevent the accumulation of iron in the striatum or nucleus 
accumbens. 
TABLE 1 
Hermatological and brain iron concentration in neonatal iron-deficient and control rats
1,2
 
             Nucleus 
  Body  Hct     Accumbens      Prefrontal  Ventral midbrain  
Treatment n Age Weight      (volume fraction)        Hb        Striatum Fe       Fe             cortex Fe            Fe 
   d     g              g/L       ---------------------------- μmol/g ------------------------------ 
Control  10 14          41 ± 1.4        0.25 ± 0.003           89 ± 3    13.5 ± 1.6    12.4 ± 3.5           1.6 ± 0.1       2.0 ± 0.2 
Iron deficient 10 14 30 ± 1.6*     0.14 ± 0.006           45 ± 1*   3.9 ± 0.3*    4.8 ± 0.4*           2.5 ± 0.1*    1.6 ± 0.1 
Control  12 21 55 ± 1.9       0.27 ± 0.003         59 ± 3     15.2 ± 0.8    11.1 ± 0.3           15.5 ± 0.3    11.0 ± 1.7 
Iron deficient 12 21 43 ± 0.6*     0.13 ± 0.005*         44 ± 2*   12.6 ± 1.9    11.4 ± 1.3           7.0 ± 0.7*    8.0 ± 1.0 
1 
Values are means ± SEM. For all variables, diet and age were significant effects )P < 0.001) but there were 
no interactions. 
* Different from the control of the same age, P < 0.05. 
2
 Hct, hematocrit; Hb, hemoglobin 
 
Binding of D1, D2 and DAT ligands. Neonatal iron deficiency affected D1R density with a significantly lower 
D1R density in the striatum at PND 14 [F (1,12) = 12.3, ω
2
 = 0.221] (Table 2). D2R density was significantly 
lower in striatum at PND 14, [F (1,12) = 10.9, ω
2
 = 0.181], but was significantly higher in the PFC [F (1,12) = 
8.4, ω
2
 = 0.162]. Iron deficiency decreased the density of the DAT in the accumbens and increased its density in 
the prefrontal cortex [F(1,12) = 12.2, ω
2
 = 0.192]. 
TABLE 2 
Brain dopamine receptor and transporter densities in iron-deficient and control rats that experienced 
Iron deficiency pre- and postweaning
1,2
 
    D1R    D2R                  DAT 
                 -------------------------------------     ------------------------------------------                ------------------------------------------ 
Brain region  14d     21d          49d                   14d             21d              49d 
Striatum        Control       0.60 ± 0.04  0.46 ± 0.03  0.50 ± 0.04      1.40 ± 0.72   1.94 ± 0.09  1.75 ± 0.08      19.2 ± 1.4  14.3 ± 0.7    18.8 ± 1.6 
    Iron deficient 0.51 ± 0.04* 0.42 ± 0.03  0.39 ± 0.05*    0.87 ± 0.43* 1.73 ± 0.08  1.35 ± 0.06*   19.9 ± 1.4   15.1 ± 1.9    16.9 ± 1.3* 
Nucleus        Control      0.49 ± 0.02   0.25 ± 0.02  0.55 ± 0.03      0.58 ± 0.33   0.96 ± 0.02  1.25 ± 0.06      15.3 ± 1.5  14.2 ± 1.5    18.6 ± 0.8 
accumbens Iron deficient   0.36 ± 0.05  0.23 ± 0.02   0.47 ± 0.02*     0.45 ± 0.23   0.91 ± 0.06  0.92 ± 0.05*    7.9 ± 1.9* 11.5 ± 2.3*  13.6 ± 1.4* 
Prefrontal       Control      0.17 ± 0.01   0.10 ± 0.01   0.11 ± 0.01      0.06 ± 0.08   0.06 ± 0.01  0.08 ±  0.01     4.1 ± 0.5    4.9 ± 0.1      3.5 ± 0.2     
cortex      Iron deficient    0.16 ± 0.01  0.09 ± 0.01   0.13 ± 0.01      0.11 ± 0.03* 0.05 ± 0.01* 0.19 ± 0.01*   5.7 ± 0.3*   3.6 ± 0.4*   4.6 ± 0.1* 
Ventral           Control      0.11 ± 0.01  0.09 ± 0.02   0.08 ± 0.01      0.19 ± 0.10   0.08 ± 0.01   0.12 ± 0.01     5.6 ± 0.4    6.1 ± 0.4      3.5 ± 0.2 
Midbrain  Iron deficient    0.09 ± 0.01  0.10 ± 0.01   0.08 ± 0.01      0.20 ± 0.08   0.05 ± 0.01*  0.11 ± 0.01    6.0 ± 0.9     7.4 ± 0.9*    3.2 ± 0.2 
1
 Values are means ± SEM, For all variables, diet and age were significant effects (P < 0.001) but there were 
no interactions. 
* Different from the control of the same age, P < 0.05. 
2
 D1R dopamine D1 receptor; DAT, dopamine transporter, nmol/mg protein. 
 
The densities of D1R and D2R in iron-deficient rats at PND 21 in striatum and in the nucleus accumbens were 
not different from in controls (Table 2, Fig. 1a,b). In nucleus accumbens and PFC, the DAT density in ID rats 
was significantly lower than in controls [nucleus accumbens and PFC F (1,22) = 9.6, ω
2
 = 0.266, F (1,22) = 7.3, 
ω
2
 = 0.190, respectively]. 
 
Figure 1. Percentage of control dopamine D1 receptor (D1R), D2R, dopamine transporter (DAT) densities, 
and iron concentration in striatum (A) and nucleus accumbens (B) of rats that were iron deficient from 
postnatal day (PND) 4 to 14 (14 d), from PND 4 to 21 (21 d), and rats fed an iron-deficient diet from PND 21 
to 49 (49 d). Values are means ± SEM. See Table 1 for n. * Different from controls. 
 
The densities of D1R, D2R, and DAT were greater in controls than in ID rats in the striatum and accumbens in 
PND 49, rats {p < 0.01 in all cases]. In the PFC, D2R and DAT densities were greater in the ID rats at PND 49 
[F (1,17) = 7.7, ω
2
 = 0.216]. 
 
Postweaning iron supplementation. Iron repletion of neonatal iron-deficient rat pups commenced at weaning 
(IDCN) and resulted in significant improvements in hematologic measures, and D1R, D2R, and DAT in brain 
regions (Table 3). The rats that were iron deficient from PND 4 to 21 and then made replete (IDCN) had a body 
weight of 191 ± 10 g, Hct of 0.39 ± 0.02 and liver iron of 2.54 ± 0.38 μmol/g. The rats that were iron sufficient 
throughout PND 4-49 (CNCN) had a body weight of 212 ± 13 g, Hct of 0.43 ± 0.02 and liver iron of 1.93 ± 
0.36 μmol/g tissue. D1R density was significantly lower in striatum than control levels (CNCN) [F = 1,20; ω
2
 = 
0.184] even though these rats were no longer anemic and body iron stores has been restored (Fig.2). The D2R 
density measurements, however presented the greatest surprise. They were 98 and 52% greater than in controls 
in the striatum and the nucleus accumbens, respectively [F = 1,28; ω
2
 = 0.194]. The DAT density remained 
lower in the striatum of iron-replete rats [F = 1,22; ω
2
 = 0.191] but other regions did not differ. 
 
 
Figure 2. Dopamine D1 receptor (D1R) densities (upper panel), D2R density (middle panel) and dopamine 
transporter (DAT) density (lower panel) in brains of iron-replete rats and control rats. N. Acc., nucleus 
accumbens; MPFC, medial prefrontal cortex; VMB, ventral midbrain. Values are means ± SEM, n = 8-16.   
* Different from controls, P < 0.01; ** different from controls, P < 0.001. 
 
Behavioral testing. Iron-deficient rats at PND 21 showed significantly decreased levels of spontaneous 
movement and exploration of a novel environment than age-matched controls [F (1,10) = 7.7, ω
2
 = 0.245]. Iron 
repletion for 4 wk did not completely correct this behavioral effect because a significant difference in 
locomotion remained at PND 49 [F (1,10) = 11.2, ω
2
 = 0.493] (Fig. 3a). Stereotypy (number of repeated 
movements) was also significantly lower in iron-deficient neonatal rats [F (1,8) = 4.6, ω
2
 = 0.177]; however, 
postweaning iron repletion reversed this effect (Fig. 3b). 
 
 
Figures 3. Total distance traveled by male rats of variable iron status in an open field chamber for a 20-min 
period (A) and number of repeated movements (B) at both 21 and 49 d of age. The groups of rats are controls 
(CNCN), neonatal iron-deficient rats made iron replete (IDCN) and postweaning iron-deficient rats (CNID). 
Values are means ± SEM. See Table 2 for n. * Different from other groups, P < 0.001; ** different from 
CNCN, P < 0.001. 
 
Discussion 
The current experiments answered three important questions: 1) Does deficiency during the neonatal period 
change DA function? 2) Is there an effect of the duration of iron deficiency during the neonatal period on DA? 
3) Is there a “complete normalization” of DA metabolism after iron repletion? We found that neonatal rat pups 
subjected to iron deficiency for only 10 or 17 d (PND 14 or 21) developed changes in DA function and behavior 
that were not corrected despite normalization of hematology and iron stores. This was suspected on the basis of 
our earlier studies that showed that brief periods of neonatal iron deficiency were sufficient to significantly alter 
brain iron concentrations (17). In their study, 2 wk of iron therapy did normalize the iron content of most 
regions of the brain, but some behaviors were resistant to complete normalization within that short time period 
(17, 21). The current report provides some possible biologic explanations for those observations because we 
were able to demonstrate that DA metabolism is also not completely normalized after a longer 4-wk repletion 
period. 
 
The acquisition of iron by different regions is quite different in the first neonatal period studied compared with 
the iron accumulation in the second neonatal period. The absolute concentrations of iron in the four regions 
examined show that striatum and accumbens accumulated much more iron in the first 10-14 d of the neonatal 
period than in the next 7 d, whereas the PFC and ventral midbrain displayed a “burst” of iron accumulation 
between PND 14 and 21. Thus, the effect of iron deficiency on brain iron concentrations is very dependent on 
the “timing” of the dietary deprivation. For instance, the striatum is sensitive to dietary iron depletion from 
PND 4 to 14, but an additional 7 d of dietary iron restriction did not reduce iron concentrations to levels below 
those at PND 14. In contrast, the nucleus accumbens is “insensitive” to dietary iron restriction during the first 
10 d of iron deficiency but then “falls behind” very substantially in iron acquisition over the next week of 
growth when that region is very actively accumulating iron. The observation that high rates of iron 
accumulation occur in different brain regions at different ages of postnatal life was noted previously (17). The 
biological basis of this relative iron accumulation is not understood, but is likely mediated by changes in the 
cellular iron uptake proteins, divalent metal transporter protein and transferring receptor, as well as changes in 
iron requirements with regional brain growth and development (21, 26, 27). Iron requirements for myelin 
production and oligodendrocyte metabolism would be expected to be high during the development of white 
matter regions, but other biological processes that require iron remain to be explored (10, 17). 
 
A key finding of this study is that the regional densities of DAT and D2R closely and positively follow the 
changes in  iron concentration across the different ages studied. We previously observed a strong correlation 
between regional iron concentration and aspects of DA metabolism in postweaning iron-deficient rats 
(13,22,28).  Multivariate regression analyses demonstrated that combinations of both iron concentrations and 
DA variables explained between 50 and 67% of the variation in exploratory behaviors and in latency in light-
dark box behaviors in those studies. The argument that only DA variables and only certain brain regions are 
affected exclusively by iron deficiency is not likely to be valid (28); those studies documented only associations 
between particular dopaminergic pathways and behaviors known to be affected by dysfunction in those brain 
regions and pathways. 
 
Dopaminergic neurons express transporters and receptors at different times in development and also experience 
a substantial amount of “pruning” of neural circuits with postnatal aging (29-31). D2R density in some rat brain 
regions doubles from PND 7 to 14, increases by another 20% from PND 14 to 21 and by another 20-50% by 
PND 28 (31). The density of the DAT increases steadily throughout neonatal development to a maximal level 
by adulthood. In contrast, the density of D1R in primary dopaminergic regions is not age dependent during the 
neonatal period (28,30). Our demonstration that the densities of dopamine receptors rise and fall with iron status 
may indicate that iron has a role in DA neuron-specific apoptosis as well as specific effects on the expression of 
these proteins. This idea has been explored in cell culture in which acute iron chelation in both PC12 cells and 
neuroblastoma cells showed dose-response relationships between the expression of the DAT and amount of 
cellular iron deficiency (32). 
 
The final key observation from the current study was that 4 wk of iron repletion resulted in incomplete 
normalization of DAT and receptor densities and some improvement, but not complete normalization, in all 
behaviors that were examined. Thus, our previous hypothesis that longer periods of iron repletion in rats would 
normalize behaviors is only partially supported (33,34). There is thus some support for the notion that even 
longer periods of iron therapy would result in complete normalization of the behaviors related to exploration of 
the environment. The biological explanation of the need for this longer period of iron therapy must hinge on 
events other than simply the iron content of a brain region because iron concentration is normalized in most 
brain regions within 14 d of dietary treatment (21, 24). It is tempting to argue that the basis of the alterations in 
some behaviors that are resistant to normalization are related to irreversible changes in dopamine transporter 
and receptor levels in certain brain regions. We, and others, have already established that iron-deficient rats 
have altered motor activity, exploratory behavior and stereotypy (14-16, 21). They also show more anxiety in 
both open field and light box-dark box behavior paradigms. Regression analysis showed these behaviors to be 
highly related to dopaminergic function in the nigrostriatal and mesocorticolimbic pathways (11,35) as well as 
to iron concentrations in ventral midbrain and striatum (34). As noted elsewhere, a number of other possible 
biological explanations remain viable at this time and are being explored (35).  
 
In conclusion, these studies of neonatal iron deficiency and postweaning iron repletion provide important new 
evidence regarding the relationship of brain iron deficiency to behavior in several ways: 1) dopaminergic tracts 
are affected by iron deficiency during the neonatal period; 2) the early neonatal period has a different 
“susceptibility” than the second half of the neonatal period; 3) iron therapy for 4 wk normalizes DA transporter 
and receptor densities in the dopaminergic tracts, with the exception of D1R and DAT densities in striatum; and 
4), behaviors known to be dependent on functioning of the striatal dopaminergic neurons remain despite iron 
therapy. Whether human infants with iron deficiency anemia also demonstrate this dopaminergic sensitivity to 
regional brain iron concentration must be determined. We contend, however, that these rodent studies strongly 
support such a hypothesis. 
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